Exelixis Inc. buy Brookline Capital Management
Start price
23.12.24
/
50%
€31.85
Target price
23.12.25
-
Performance (%)
24.87%
End price
24.12.25
€39.77
Summary
This prediction ended on 24.12.25 with a price of €39.77. The prediction had a final performance of 24.87%. Brookline_Capital_Ma has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Exelixis Inc. | 0.936% | 0.936% | 26.365% |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % |
Comments by Brookline_Capital_Ma for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) is now covered by analysts at Brookline Capital Management. They set a "buy" rating on the stock.
Ratings data for EXEL provided by MarketBeat
In the thread Trading Exelixis Inc.
Die von Brookline_Capital_Ma gewählte maximale Laufzeit wurde überschritten